Keyphrases
Childrens
100%
Oncology
100%
Rhabdomyosarcoma
100%
Clinical Trials
37%
Children's Oncology Group
25%
Risk Stratification
12%
Quality of Life
12%
Patient Engagement
12%
Phase III Clinical Trial
12%
Therapeutic Efficacy
12%
Soft Tissue Sarcoma
12%
Drug Efficacy
12%
Novel Agents
12%
Treatment Toxicity
12%
Risk Treatment
12%
Patient Well-being
12%
New Treatment Options
12%
Therapeutic Toxicity
12%
Drug Response Biomarkers
12%
Biomarkers of Response
12%
Knowledge Generation
12%
Systematic Planning
12%
Toxicity Reduction
12%
Life Engagement
12%
Trial Implementation
12%
Clinical Behavior
12%
Efficient Trials
12%
Recent Advancements
12%
Trial Development
12%
Preclinical-to-clinical Translation
12%
Medicine and Dentistry
Oncology
100%
Rhabdomyosarcoma
100%
Clinical Trial
50%
Combination Therapy
25%
Quality of Life
25%
Biological Marker
12%
Risk Stratification
12%
Treatment Response
12%
Soft Tissue Sarcoma
12%